Condition: Opioid Use Disorder · Methadone · Cannabis · Sponsor: BC Centre on Substance Use
This pilot study will evaluate the feasibility and safety of using 1:1 tetrahydrocannabinol (THC):Cannabidiol (CBD) cannabis oil as an adjunct therapy to methadone-based Opioid Agonist Therapy (OAT) for individuals with opioid use disorder (OUD) in a community setting.
This description comes directly from the study's public registry record.
Josie Kanu, BSc · 6045001102 · josie.kanu@bccsu.ubc.ca
Always discuss trial participation with your own doctor first.
| Rapid Access Addiction Clinic (RAAC), St. Paul's Hospital | Vancouver, British Columbia, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05985850